Clinical Trials Directory

Trials / Conditions / Hydroxychloroquine

Hydroxychloroquine

15 registered clinical trials studyying Hydroxychloroquine.

StatusTrialSponsorPhase
UnknownHydroxychloroquine Combined With Gemcitabine in the Treatment of Advanced Non-small Cell Lung Cancer
NCT05647330
Henan Cancer HospitalPhase 2
UnknownAt the Heart of the Matter - Speckle Tracking Echocardiography in Lupus Mothers and Their Offspring
NCT05451277
Evelyne Vinet—
UnknownLow-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professiona
NCT04340349
Instituto Nacional de RehabilitacionEARLY_Phase 1
CompletedIMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT
NCT04347798
University of Alberta—
UnknownPrevention of COVID19 Infection in Nursing Homes by Chemoprophylaxis With Hydroxychloroquine (PREVICHARM)
NCT04400019
University of MalagaPhase 2 / Phase 3
CompletedRapid Development and Implementation of a Remote ECG-monitored Prospective Randomized Clinical Trial During a
NCT04652648
Bryn Mawr HospitalPhase 4
TerminatedProtect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-
NCT04363827
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSPhase 2
CompletedA Comparative Study on Ivermectin and Hydroxychloroquine on the COVID19 Patients in Bangladesh
NCT04434144
Upazila Health & Family Planning Officer's (UHFPO) Office, Chakoria, Cox's Bazar—
WithdrawnEffect of Hydroxychloroquine in COVID-19 Positive Pregnant Women
NCT04354441
Sir Mortimer B. Davis - Jewish General HospitalPhase 2
WithdrawnAssessment of the Efficacy and Safety of (HCQ) as a Prophylaxis for COVID19 for Health Professionals
NCT04349228
Abderrahmane Mami HospitalPhase 3
UnknownHydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP)
NCT04363450
Louisiana State University Health Sciences Center in New OrleansPhase 3
UnknownHEalth Care Worker pROphylaxis Against COVID-19: The HERO Trial
NCT04352946
GeoSentinel FoundationPhase 3
CompletedFavipiravir Plus Hydroxychloroquine and Lopinavir/Ritonavir Plus Hydroxychloroquine in COVID-19
NCT04376814
Baqiyatallah Medical Sciences UniversityN/A
CompletedA Study of Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy
NCT02942381
Peking University First HospitalPhase 2
CompletedHydroxychloroquine for the Prevention of Cardiovascular Events in Myocardial Infarction Patients - a Safety Pi
NCT02648464
Helsinki University Central HospitalPhase 4